nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—CDH5—primary biliary cirrhosis	0.818	1	CbGaD
Lenalidomide—TNFSF11—Osteoblast Signaling—COL1A1—primary biliary cirrhosis	0.00639	0.208	CbGpPWpGaD
Lenalidomide—Thalidomide—NFKB1—primary biliary cirrhosis	0.00379	1	CrCbGaD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00235	0.0764	CbGpPWpGaD
Lenalidomide—CDH5—epithelium—primary biliary cirrhosis	0.00198	0.261	CbGeAlD
Lenalidomide—CDH5—smooth muscle tissue—primary biliary cirrhosis	0.00191	0.252	CbGeAlD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—TAB1—primary biliary cirrhosis	0.00179	0.0584	CbGpPWpGaD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00178	0.0579	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—ELMO1—primary biliary cirrhosis	0.00137	0.0447	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—ELMO1—primary biliary cirrhosis	0.0013	0.0422	CbGpPWpGaD
Lenalidomide—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00121	0.0395	CbGpPWpGaD
Lenalidomide—CDH5—liver—primary biliary cirrhosis	0.00112	0.148	CbGeAlD
Lenalidomide—TNFSF11—IL6-mediated signaling events—TYK2—primary biliary cirrhosis	0.00106	0.0345	CbGpPWpGaD
Lenalidomide—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00098	0.0319	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—RPS6KA4—primary biliary cirrhosis	0.000808	0.0263	CbGpPWpGaD
Lenalidomide—TNFSF11—RANKL/RANK Signaling Pathway—NFKB1—primary biliary cirrhosis	0.000729	0.0237	CbGpPWpGaD
Lenalidomide—CRBN—liver—primary biliary cirrhosis	0.000712	0.094	CbGeAlD
Lenalidomide—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.000697	0.0227	CbGpPWpGaD
Lenalidomide—PTGS2—gall bladder—primary biliary cirrhosis	0.000661	0.0873	CbGeAlD
Lenalidomide—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000536	0.0175	CbGpPWpGaD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000469	0.0153	CbGpPWpGaD
Lenalidomide—CDH5—VEGFA-VEGFR2 Pathway—TYK2—primary biliary cirrhosis	0.000416	0.0136	CbGpPWpGaD
Lenalidomide—CDH5—Signaling by VEGF—TYK2—primary biliary cirrhosis	0.000393	0.0128	CbGpPWpGaD
Lenalidomide—Neutropenia—Colchicine—primary biliary cirrhosis	0.000371	0.00264	CcSEcCtD
Lenalidomide—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000365	0.0026	CcSEcCtD
Lenalidomide—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000365	0.0026	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00259	CcSEcCtD
Lenalidomide—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000364	0.00259	CcSEcCtD
Lenalidomide—PTGS2—Eicosanoid Synthesis—GGT1—primary biliary cirrhosis	0.000358	0.0117	CbGpPWpGaD
Lenalidomide—Asthma—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Asthma—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Influenza—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Influenza—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00254	CcSEcCtD
Lenalidomide—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00249	CcSEcCtD
Lenalidomide—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00035	0.00249	CcSEcCtD
Lenalidomide—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00247	CcSEcCtD
Lenalidomide—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.000347	0.00247	CcSEcCtD
Lenalidomide—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000347	0.00247	CcSEcCtD
Lenalidomide—Stomatitis—Colchicine—primary biliary cirrhosis	0.000345	0.00246	CcSEcCtD
Lenalidomide—Bronchitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00244	CcSEcCtD
Lenalidomide—Bronchitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000343	0.00244	CcSEcCtD
Lenalidomide—PTGS2—epithelium—primary biliary cirrhosis	0.000342	0.0452	CbGeAlD
Lenalidomide—Abdominal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000342	0.00244	CcSEcCtD
Lenalidomide—Abdominal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000342	0.00244	CcSEcCtD
Lenalidomide—Haematuria—Colchicine—primary biliary cirrhosis	0.000337	0.0024	CcSEcCtD
Lenalidomide—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000333	0.00238	CcSEcCtD
Lenalidomide—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000333	0.00238	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00236	CcSEcCtD
Lenalidomide—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000331	0.00236	CcSEcCtD
Lenalidomide—Agranulocytosis—Colchicine—primary biliary cirrhosis	0.00033	0.00235	CcSEcCtD
Lenalidomide—PTGS2—smooth muscle tissue—primary biliary cirrhosis	0.00033	0.0435	CbGeAlD
Lenalidomide—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00235	CcSEcCtD
Lenalidomide—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000329	0.00235	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00232	CcSEcCtD
Lenalidomide—Photosensitivity reaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00232	CcSEcCtD
Lenalidomide—Weight increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00231	CcSEcCtD
Lenalidomide—Weight increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000325	0.00231	CcSEcCtD
Lenalidomide—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000323	0.0105	CbGpPWpGaD
Lenalidomide—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000323	0.0023	CcSEcCtD
Lenalidomide—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000323	0.0023	CcSEcCtD
Lenalidomide—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00228	CcSEcCtD
Lenalidomide—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00032	0.00228	CcSEcCtD
Lenalidomide—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00227	CcSEcCtD
Lenalidomide—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00227	CcSEcCtD
Lenalidomide—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00227	CcSEcCtD
Lenalidomide—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000318	0.00227	CcSEcCtD
Lenalidomide—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000317	0.00226	CcSEcCtD
Lenalidomide—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000317	0.00226	CcSEcCtD
Lenalidomide—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.000316	0.00225	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00223	CcSEcCtD
Lenalidomide—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00223	CcSEcCtD
Lenalidomide—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00223	CcSEcCtD
Lenalidomide—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000313	0.00223	CcSEcCtD
Lenalidomide—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00222	CcSEcCtD
Lenalidomide—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000312	0.00222	CcSEcCtD
Lenalidomide—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000309	0.0022	CcSEcCtD
Lenalidomide—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000309	0.0022	CcSEcCtD
Lenalidomide—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000309	0.0022	CcSEcCtD
Lenalidomide—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000309	0.0022	CcSEcCtD
Lenalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000308	0.01	CbGpPWpGaD
Lenalidomide—Sweating—Ursodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00217	CcSEcCtD
Lenalidomide—Sweating—Chenodeoxycholic acid—primary biliary cirrhosis	0.000305	0.00217	CcSEcCtD
Lenalidomide—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00216	CcSEcCtD
Lenalidomide—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000303	0.00216	CcSEcCtD
Lenalidomide—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00214	CcSEcCtD
Lenalidomide—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000301	0.00214	CcSEcCtD
Lenalidomide—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00214	CcSEcCtD
Lenalidomide—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.0003	0.00214	CcSEcCtD
Lenalidomide—Sinusitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00213	CcSEcCtD
Lenalidomide—Sinusitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000298	0.00213	CcSEcCtD
Lenalidomide—Eye disorder—Colchicine—primary biliary cirrhosis	0.000297	0.00212	CcSEcCtD
Lenalidomide—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000294	0.00958	CbGpPWpGaD
Lenalidomide—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00204	CcSEcCtD
Lenalidomide—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000287	0.00204	CcSEcCtD
Lenalidomide—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000286	0.00204	CcSEcCtD
Lenalidomide—Rhinitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000286	0.00204	CcSEcCtD
Lenalidomide—Rhinitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000286	0.00204	CcSEcCtD
Lenalidomide—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00203	CcSEcCtD
Lenalidomide—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000285	0.00203	CcSEcCtD
Lenalidomide—Pharyngitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000283	0.00202	CcSEcCtD
Lenalidomide—Pharyngitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000283	0.00202	CcSEcCtD
Lenalidomide—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000282	0.00201	CcSEcCtD
Lenalidomide—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000282	0.00201	CcSEcCtD
Lenalidomide—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.000281	0.002	CcSEcCtD
Lenalidomide—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.000281	0.002	CcSEcCtD
Lenalidomide—Alopecia—Colchicine—primary biliary cirrhosis	0.000281	0.002	CcSEcCtD
Lenalidomide—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00028	0.002	CcSEcCtD
Lenalidomide—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00028	0.002	CcSEcCtD
Lenalidomide—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00028	0.00199	CcSEcCtD
Lenalidomide—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00028	0.00199	CcSEcCtD
Lenalidomide—Malnutrition—Colchicine—primary biliary cirrhosis	0.000277	0.00197	CcSEcCtD
Lenalidomide—Visual impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00196	CcSEcCtD
Lenalidomide—Visual impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.000275	0.00196	CcSEcCtD
Lenalidomide—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000267	0.0019	CcSEcCtD
Lenalidomide—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000267	0.0019	CcSEcCtD
Lenalidomide—Tinnitus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000266	0.0019	CcSEcCtD
Lenalidomide—Tinnitus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000266	0.0019	CcSEcCtD
Lenalidomide—Muscle spasms—Colchicine—primary biliary cirrhosis	0.000266	0.00189	CcSEcCtD
Lenalidomide—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00189	CcSEcCtD
Lenalidomide—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000265	0.00189	CcSEcCtD
Lenalidomide—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00184	CcSEcCtD
Lenalidomide—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000259	0.00184	CcSEcCtD
Lenalidomide—Immune system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00184	CcSEcCtD
Lenalidomide—Immune system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000258	0.00184	CcSEcCtD
Lenalidomide—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00183	CcSEcCtD
Lenalidomide—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000257	0.00183	CcSEcCtD
Lenalidomide—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00182	CcSEcCtD
Lenalidomide—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000256	0.00182	CcSEcCtD
Lenalidomide—Anaemia—Colchicine—primary biliary cirrhosis	0.000256	0.00182	CcSEcCtD
Lenalidomide—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000255	0.00182	CcSEcCtD
Lenalidomide—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000255	0.00182	CcSEcCtD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—primary biliary cirrhosis	0.000254	0.00828	CbGpPWpGaD
Lenalidomide—Angioedema—Colchicine—primary biliary cirrhosis	0.000253	0.0018	CcSEcCtD
Lenalidomide—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000252	0.0018	CcSEcCtD
Lenalidomide—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000252	0.0018	CcSEcCtD
Lenalidomide—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00177	CcSEcCtD
Lenalidomide—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000248	0.00177	CcSEcCtD
Lenalidomide—Leukopenia—Colchicine—primary biliary cirrhosis	0.000248	0.00176	CcSEcCtD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—primary biliary cirrhosis	0.000247	0.00805	CbGpPWpGaD
Lenalidomide—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00174	CcSEcCtD
Lenalidomide—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000245	0.00174	CcSEcCtD
Lenalidomide—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000244	0.00174	CcSEcCtD
Lenalidomide—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000244	0.00174	CcSEcCtD
Lenalidomide—Nervousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00172	CcSEcCtD
Lenalidomide—Nervousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000241	0.00172	CcSEcCtD
Lenalidomide—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00171	CcSEcCtD
Lenalidomide—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00024	0.00171	CcSEcCtD
Lenalidomide—Muscle spasms—Chenodeoxycholic acid—primary biliary cirrhosis	0.000239	0.0017	CcSEcCtD
Lenalidomide—Muscle spasms—Ursodeoxycholic acid—primary biliary cirrhosis	0.000239	0.0017	CcSEcCtD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—PPARGC1A—primary biliary cirrhosis	0.000236	0.00768	CbGpPWpGaD
Lenalidomide—Myalgia—Colchicine—primary biliary cirrhosis	0.000235	0.00168	CcSEcCtD
Lenalidomide—Arthralgia—Colchicine—primary biliary cirrhosis	0.000235	0.00168	CcSEcCtD
Lenalidomide—Ill-defined disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00164	CcSEcCtD
Lenalidomide—Ill-defined disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000231	0.00164	CcSEcCtD
Lenalidomide—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00164	CcSEcCtD
Lenalidomide—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00023	0.00164	CcSEcCtD
Lenalidomide—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000227	0.00162	CcSEcCtD
Lenalidomide—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000227	0.00162	CcSEcCtD
Lenalidomide—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000224	0.0016	CcSEcCtD
Lenalidomide—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000224	0.0016	CcSEcCtD
Lenalidomide—Vertigo—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00159	CcSEcCtD
Lenalidomide—Vertigo—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00159	CcSEcCtD
Lenalidomide—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00159	CcSEcCtD
Lenalidomide—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000223	0.00159	CcSEcCtD
Lenalidomide—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00158	CcSEcCtD
Lenalidomide—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000222	0.00158	CcSEcCtD
Lenalidomide—Shock—Colchicine—primary biliary cirrhosis	0.000222	0.00158	CcSEcCtD
Lenalidomide—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000221	0.00158	CcSEcCtD
Lenalidomide—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000221	0.00157	CcSEcCtD
Lenalidomide—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00156	CcSEcCtD
Lenalidomide—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00022	0.00156	CcSEcCtD
Lenalidomide—Skin disorder—Colchicine—primary biliary cirrhosis	0.000219	0.00156	CcSEcCtD
Lenalidomide—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00156	CcSEcCtD
Lenalidomide—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000218	0.00156	CcSEcCtD
Lenalidomide—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000217	0.00154	CcSEcCtD
Lenalidomide—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000217	0.00154	CcSEcCtD
Lenalidomide—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00153	CcSEcCtD
Lenalidomide—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000215	0.00153	CcSEcCtD
Lenalidomide—ABCB1—epithelium—primary biliary cirrhosis	0.000212	0.0279	CbGeAlD
Lenalidomide—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000212	0.00151	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—primary biliary cirrhosis	0.000211	0.00688	CbGpPWpGaD
Lenalidomide—Hypotension—Colchicine—primary biliary cirrhosis	0.000211	0.0015	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00021	0.0015	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00021	0.0015	CcSEcCtD
Lenalidomide—Discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00149	CcSEcCtD
Lenalidomide—Discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000209	0.00149	CcSEcCtD
Lenalidomide—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00147	CcSEcCtD
Lenalidomide—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000207	0.00147	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000206	0.00146	CcSEcCtD
Lenalidomide—Confusional state—Chenodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00146	CcSEcCtD
Lenalidomide—Confusional state—Ursodeoxycholic acid—primary biliary cirrhosis	0.000204	0.00146	CcSEcCtD
Lenalidomide—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00144	CcSEcCtD
Lenalidomide—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000203	0.00144	CcSEcCtD
Lenalidomide—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00144	CcSEcCtD
Lenalidomide—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000201	0.00144	CcSEcCtD
Lenalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—primary biliary cirrhosis	0.0002	0.00652	CbGpPWpGaD
Lenalidomide—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00142	CcSEcCtD
Lenalidomide—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00142	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000199	0.00649	CbGpPWpGaD
Lenalidomide—PTGS2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000199	0.00648	CbGpPWpGaD
Lenalidomide—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00142	CcSEcCtD
Lenalidomide—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00142	CcSEcCtD
Lenalidomide—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00141	CcSEcCtD
Lenalidomide—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000199	0.00141	CcSEcCtD
Lenalidomide—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00141	CcSEcCtD
Lenalidomide—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000198	0.00141	CcSEcCtD
Lenalidomide—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000197	0.0014	CcSEcCtD
Lenalidomide—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000197	0.0014	CcSEcCtD
Lenalidomide—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000196	0.0014	CcSEcCtD
Lenalidomide—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000196	0.0014	CcSEcCtD
Lenalidomide—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000196	0.0014	CcSEcCtD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000196	0.00636	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000195	0.00139	CcSEcCtD
Lenalidomide—Fatigue—Colchicine—primary biliary cirrhosis	0.000195	0.00139	CcSEcCtD
Lenalidomide—PTGS2—liver—primary biliary cirrhosis	0.000194	0.0256	CbGeAlD
Lenalidomide—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00138	CcSEcCtD
Lenalidomide—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000193	0.00138	CcSEcCtD
Lenalidomide—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00135	CcSEcCtD
Lenalidomide—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000189	0.00135	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000185	0.00132	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000185	0.00132	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000185	0.00131	CcSEcCtD
Lenalidomide—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000183	0.00131	CcSEcCtD
Lenalidomide—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000183	0.00131	CcSEcCtD
Lenalidomide—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000182	0.0013	CcSEcCtD
Lenalidomide—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000182	0.0013	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000181	0.00589	CbGpPWpGaD
Lenalidomide—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00129	CcSEcCtD
Lenalidomide—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000181	0.00129	CcSEcCtD
Lenalidomide—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00128	CcSEcCtD
Lenalidomide—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00018	0.00128	CcSEcCtD
Lenalidomide—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00018	0.00585	CbGpPWpGaD
Lenalidomide—Urticaria—Colchicine—primary biliary cirrhosis	0.000179	0.00128	CcSEcCtD
Lenalidomide—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00127	CcSEcCtD
Lenalidomide—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000178	0.00127	CcSEcCtD
Lenalidomide—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000178	0.00127	CcSEcCtD
Lenalidomide—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000176	0.00126	CcSEcCtD
Lenalidomide—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000176	0.00126	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.000176	0.00573	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00125	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00125	CcSEcCtD
Lenalidomide—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00125	CcSEcCtD
Lenalidomide—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000175	0.00125	CcSEcCtD
Lenalidomide—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00124	CcSEcCtD
Lenalidomide—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00124	CcSEcCtD
Lenalidomide—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00124	CcSEcCtD
Lenalidomide—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000173	0.00124	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000173	0.00563	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—primary biliary cirrhosis	0.000168	0.00546	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—AQP4—primary biliary cirrhosis	0.000167	0.00545	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.000167	0.00119	CcSEcCtD
Lenalidomide—Feeling abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.000167	0.00119	CcSEcCtD
Lenalidomide—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000166	0.00118	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00118	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000166	0.00118	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—primary biliary cirrhosis	0.000164	0.00535	CbGpPWpGaD
Lenalidomide—Asthenia—Colchicine—primary biliary cirrhosis	0.000162	0.00115	CcSEcCtD
Lenalidomide—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000161	0.00115	CcSEcCtD
Lenalidomide—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000161	0.00115	CcSEcCtD
Lenalidomide—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00114	CcSEcCtD
Lenalidomide—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00114	CcSEcCtD
Lenalidomide—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00114	CcSEcCtD
Lenalidomide—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00016	0.00114	CcSEcCtD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—primary biliary cirrhosis	0.00016	0.00521	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCR5—primary biliary cirrhosis	0.00016	0.00521	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000158	0.00513	CbGpPWpGaD
Lenalidomide—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000154	0.0011	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000154	0.00502	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00106	CcSEcCtD
Lenalidomide—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000149	0.00106	CcSEcCtD
Lenalidomide—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000145	0.00104	CcSEcCtD
Lenalidomide—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000145	0.00104	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CXCL9—primary biliary cirrhosis	0.000145	0.00473	CbGpPWpGaD
Lenalidomide—Vomiting—Colchicine—primary biliary cirrhosis	0.000143	0.00102	CcSEcCtD
Lenalidomide—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00102	CcSEcCtD
Lenalidomide—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000143	0.00102	CcSEcCtD
Lenalidomide—Rash—Colchicine—primary biliary cirrhosis	0.000142	0.00101	CcSEcCtD
Lenalidomide—Dermatitis—Colchicine—primary biliary cirrhosis	0.000142	0.00101	CcSEcCtD
Lenalidomide—Headache—Colchicine—primary biliary cirrhosis	0.000141	0.00101	CcSEcCtD
Lenalidomide—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000139	0.000988	CcSEcCtD
Lenalidomide—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000139	0.000988	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—ELMO1—primary biliary cirrhosis	0.000134	0.00437	CbGpPWpGaD
Lenalidomide—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000134	0.000955	CcSEcCtD
Lenalidomide—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000134	0.000955	CcSEcCtD
Lenalidomide—Nausea—Colchicine—primary biliary cirrhosis	0.000134	0.000955	CcSEcCtD
Lenalidomide—PTGS2—C-MYB transcription factor network—TAB1—primary biliary cirrhosis	0.000131	0.00426	CbGpPWpGaD
Lenalidomide—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000129	0.000919	CcSEcCtD
Lenalidomide—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000129	0.000919	CcSEcCtD
Lenalidomide—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.000911	CcSEcCtD
Lenalidomide—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.000911	CcSEcCtD
Lenalidomide—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00091	CcSEcCtD
Lenalidomide—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000128	0.00091	CcSEcCtD
Lenalidomide—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000127	0.000905	CcSEcCtD
Lenalidomide—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000127	0.000905	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—GGT1—primary biliary cirrhosis	0.000127	0.00413	CbGpPWpGaD
Lenalidomide—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00012	0.000858	CcSEcCtD
Lenalidomide—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00012	0.000858	CcSEcCtD
Lenalidomide—ABCB1—liver—primary biliary cirrhosis	0.00012	0.0158	CbGeAlD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000115	0.00373	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000112	0.00364	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.000111	0.0036	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000104	0.00338	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL10—primary biliary cirrhosis	9.65e-05	0.00314	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—primary biliary cirrhosis	8.6e-05	0.0028	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	8.08e-05	0.00263	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL4—primary biliary cirrhosis	8.05e-05	0.00262	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	7.87e-05	0.00256	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	7.86e-05	0.00256	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	7.72e-05	0.00251	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL10—primary biliary cirrhosis	7.56e-05	0.00246	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	7.34e-05	0.00239	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	7.16e-05	0.00233	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	6.94e-05	0.00226	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP3—primary biliary cirrhosis	6.9e-05	0.00225	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ALB—primary biliary cirrhosis	6.74e-05	0.00219	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL5—primary biliary cirrhosis	6.51e-05	0.00212	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—primary biliary cirrhosis	6.34e-05	0.00206	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	6.31e-05	0.00205	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	6.01e-05	0.00196	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HIF1A—primary biliary cirrhosis	5.47e-05	0.00178	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—AGT—primary biliary cirrhosis	5.45e-05	0.00177	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	5.2e-05	0.00169	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—primary biliary cirrhosis	5.12e-05	0.00167	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—LBR—primary biliary cirrhosis	5.1e-05	0.00166	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CD80—primary biliary cirrhosis	4.83e-05	0.00157	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—primary biliary cirrhosis	4.09e-05	0.00133	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TYK2—primary biliary cirrhosis	4.07e-05	0.00133	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—OGDH—primary biliary cirrhosis	3.69e-05	0.0012	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—LBR—primary biliary cirrhosis	3.62e-05	0.00118	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	3.33e-05	0.00108	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PDHX—primary biliary cirrhosis	3.29e-05	0.00107	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—primary biliary cirrhosis	3.21e-05	0.00104	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	3.21e-05	0.00104	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NFKB1—primary biliary cirrhosis	3.17e-05	0.00103	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCB4—primary biliary cirrhosis	3.09e-05	0.00101	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DLAT—primary biliary cirrhosis	3.09e-05	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	3.07e-05	0.001	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.85e-05	0.000927	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.81e-05	0.000915	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	2.75e-05	0.000896	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.62e-05	0.000851	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.61e-05	0.000851	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ELMO1—primary biliary cirrhosis	2.59e-05	0.000843	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	2.53e-05	0.000825	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.33e-05	0.000759	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NUP210—primary biliary cirrhosis	2.22e-05	0.000722	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	2.19e-05	0.000713	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	2.19e-05	0.000713	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.97e-05	0.000642	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.95e-05	0.000635	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NUP210—primary biliary cirrhosis	1.86e-05	0.000605	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT2—primary biliary cirrhosis	1.75e-05	0.000571	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ABCG2—primary biliary cirrhosis	1.73e-05	0.000562	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.51e-05	0.000493	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—GOT1—primary biliary cirrhosis	1.51e-05	0.000493	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CTGF—primary biliary cirrhosis	1.48e-05	0.000482	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT2—primary biliary cirrhosis	1.47e-05	0.000478	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.32e-05	0.000429	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GOT1—primary biliary cirrhosis	1.27e-05	0.000413	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GGT1—primary biliary cirrhosis	1.27e-05	0.000413	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.22e-05	0.000399	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.13e-05	0.000367	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HIF1A—primary biliary cirrhosis	1.05e-05	0.000343	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	1.05e-05	0.000342	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	1.04e-05	0.000339	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.02e-05	0.000332	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—primary biliary cirrhosis	9.58e-06	0.000312	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD80—primary biliary cirrhosis	9.3e-06	0.000303	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	8.99e-06	0.000293	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	8.99e-06	0.000293	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AGT—primary biliary cirrhosis	8.79e-06	0.000286	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	8e-06	0.00026	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TYK2—primary biliary cirrhosis	7.85e-06	0.000255	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—primary biliary cirrhosis	6.74e-06	0.00022	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AGT—primary biliary cirrhosis	6.23e-06	0.000203	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.78e-06	0.000156	CbGpPWpGaD
